NEOGNeogen Corporation
$11.85+111% 1Y
$11.85
$5.3652 weeks$13.99
The financials
Neogen Corporation by the numbers
Neogen Corporation (NEOG) reported revenue of $225M in Q4 2026 (quarter ended May 31, 2026), down 0.1% from the same quarter a year earlier. That came with a gross margin of 48% and net loss of $11M. For the full year FY2026, revenue was $870M (−2.7% year on year) and net income −$7.9M. Its largest product in Q4 2026 was Bacterial And General Sanitation at $47M, 40% of the disclosed total, ahead of Service at 23%. The next results filing is expected around Jan 7, 2027, the same week as a year ago.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $225M | $226M | −0.1% |
| Gross profit | $108M | $93M | +16% |
| Operating income | $3.1M | −$611M | to a profit |
| Net income | −$11M | −$612M | n/a |
| Diluted EPS | −$0.06 | −$2.82 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Bacterial And General Sanitation | $47M | 40% |
| Service | $26M | 23% |
| Natural Toxins And Allergens | $19M | 16% |
| Veterinary Instruments And Disposables | $16M | 14% |
| Genomics Services | $6.6M | 5.6% |
| Life Sciences | $1.8M | 1.5% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $116.6M (-43%)
Bacterial And General Sanitation grew +10% year on yearVeterinary Instruments And Disposables -2.4% year on year
Segment Latestquarter on quarteryear on year
- Bacterial And General Sanitation$46.7M$46.7Mquarter on quarter +11%year on year +10%+11%+10%
- Service$26.5M$26.5Mquarter on quarter +5.9%year on year +7.4%+5.9%+7.4%
- Natural Toxins And Allergens$19.2M$19.2Mquarter on quarter +7.3%year on year +3.7%+7.3%+3.7%
- Veterinary Instruments And Disposables$15.8M$15.8Mquarter on quarter +2.0%year on year -2.4%+2.0%-2.4%
- Genomics Services$6.6M$6.6Mquarter on quarter +6.2%year on year +4.5%+6.2%+4.5%
- Life Sciences$1.8M$1.8Mquarter on quarter +20%year on year +9.3%+20%+9.3%
On our screens:Stocks priced for perfection